Drug
AG200-15
AG200-15 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
100%(5 trials)
Phase Distribution
Ph phase_1
3
60%
Ph phase_3
2
40%
Phase Distribution
3
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 13 (60.0%)
Phase 32 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System
NCT02158572
completedphase_1
Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females
NCT01422135
completedphase_1
Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers
NCT01375946
completedphase_1
AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol
NCT01243580
completedphase_3
Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm
NCT01236768
Clinical Trials (5)
Showing 5 of 5 trials
NCT02158572Phase 3
Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System
NCT01422135Phase 1
Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females
NCT01375946Phase 1
Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers
NCT01243580Phase 1
AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol
NCT01236768Phase 3
Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5